An open-label extension of two pivotal clinical trials has given ophthalmologists critical, real-world evidence of the effectiveness of adalimumab as a treatment of noninfectious intermediate uveitis.
Optical coherence tomography angiography (OCTA) could play a growing role in the assessment of anterior inflammation from uveitis, according to results from a pilot study presented by Francesco Pichi, MD.
An analysis of data from the Intelligent Research in Sight (IRIS) Registry provides insights about real-world success rates for primary repair of retinal detachments, said Richard S. Kaiser, MD.
An intravitreal injection device can provide repeatable results and added comfort for the patient, removing the need for a drape and speculum.
Two patients with macular degeneration regained reading vision after receiving stem cells implanted with a new technique, according to researchers.
Preliminary research has shown that ataluren is effective in overriding the nonsense mutation in choroideremia patients, however, further research is needed.
A study has revealed that a budgetary saving per treated patient with the fluocinolone acetonide implant (Iluvien) versus ranibizumab (Lucentis) could lead to a significant cost-saving to NHS England.
Partner Perspective: Patient Case Study - CONTINUOUS MICRODOSING™ TREATMENT WITH ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19mg
Sixteen fellows and residents show just why research in retina is on the cutting edge